E-LIB Suche - Ergebnisse für: Menter, A.

1

Effect of baseline disease severity on achievement of treat..:

Reich, K. ; Mrowietz, U. ; Menter, A....
Journal of the European Academy of Dermatology and Venereology. 35 (2021) 12 - p. 2409-2414 , 2021

Link: https://doi.org/10.1111/..

2

Defining drug‐free remission of skin disease in patients wi..:

Armstrong, A.W. ; Blauvelt, A. ; Crowley, J.J....
British Journal of Dermatology. 182 (2020) 6 - p. 1484-1487 , 2020

Link: https://doi.org/10.1111/..

3

Efficacy of risankizumab in patients with moderate‐to‐sever..:

Strober, B. ; Menter, A. ; Leonardi, C....
Journal of the European Academy of Dermatology and Venereology. 34 (2020) 12 - p. 2830-2838 , 2020

Link: https://doi.org/10.1111/..

4

Ustekinumab for the treatment of moderate‐to‐severe plaque ..:

Philipp, S. ; Menter, A. ; Nikkels, A.F....
British Journal of Dermatology. 183 (2020) 4 - p. 664-672 , 2020

Link: https://doi.org/10.1111/..

5

Long-term efficacy and safety of brodalumab in psoriasis th..:

Papp, K. ; Menter, A. ; Leonardi, C....
British Journal of Dermatology. 183 (2020) 6 - p. 1037-1048 , 2020

Link: https://doi.org/10.1111/..

6

Efficacy and safety of mirikizumab (LY3074828) in the treat..:

Reich, K. ; Rich, P. ; Maari, C....
British Journal of Dermatology. 181 (2019) 1 - p. 88-95 , 2019

Link: https://doi.org/10.1111/..

7

Circulating tumor markers: harmonizing the yin and yang of ..:

Batth, I.S. ; Mitra, A. ; Manier, S....
Annals of Oncology. 30 (2019) 11 - p. 1845 , 2019

Link: https://doi.org/10.1093/..

8

Incidence of cardiovascular events among tildrakizumab‐trea..:

Bissonnette, R. ; Fernández‐Peñas, P. ; Puig, L....
Journal of the European Academy of Dermatology and Venereology. 34 (2019) 1 - p. , 2019

Link: https://doi.org/10.1111/..

9

Ixekizumab efficacy and safety in moderate-to-severe genita..:

Ryan, C. ; Menter, A. ; Guenther, L....
British Journal of Dermatology. 179 (2018) 4 - p. e177-e177 , 2018

Link: https://doi.org/10.1111/..

10

Systematic review of the real‐world evidence of adalimumab ..:

Strober, B. ; Crowley, J. ; Langley, R.G....
Journal of the European Academy of Dermatology and Venereology. 32 (2018) 12 - p. 2126-2133 , 2018

Link: https://doi.org/10.1111/..

11

伊赛珠单抗在中度至重度生殖器银屑病中的疗效和安全性:

Ryan, C. ; Menter, A. ; Guenther, L....
British Journal of Dermatology. 179 (2018) 4 - p. e189-e189 , 2018

Link: https://doi.org/10.1111/..

12

012 Efficacy and Safety of Ixekizumab in a Randomized, Doub..:

Ryan, C. ; Menter, A. ; Guenther, L....
The Journal of Sexual Medicine. 15 (2018) Supplement_1 - p. S6-S7 , 2018

Link: https://doi.org/10.1016/..

13

Efficacy and safety of ixekizumab in a randomized, double-b..:

Ryan, C. ; Menter, A. ; Guenther, L....
British Journal of Dermatology. 179 (2018) 4 - p. 844-852 , 2018

Link: https://doi.org/10.1111/..

14

Efficacy of ixekizumab compared to etanercept and placebo i..:

Menter, A. ; Warren, R.B. ; Langley, R.G....
Journal of the European Academy of Dermatology and Venereology. 31 (2017) 10 - p. 1686-1692 , 2017

Link: https://doi.org/10.1111/..

15

Quality of life instruments in psoriasis clinical trials:

Kivelevitch, D. ; Michel, P. ; Menter, A.
British Journal of Dermatology. 176 (2017) 3 - p. 563-563 , 2017

Link: https://doi.org/10.1111/..